NCT07021742 - BioHealx® Anal Fistula Device Post Market Surveillance Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 14, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Fistula-in-ano

Interventions

DEVICE

BioHealx

Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening, preventing reinfection, while allowing for drainage through the external opening during healing.

Trial Locations (2)

19010

RECRUITING

Maininle Health Lankenau, Bryn Mawr

33912

RECRUITING

The Colorectal Institute, Fort Myers

All Listed Sponsors

lead

Signum Surgical USA Inc.

INDUSTRY